Total Payments
$8,133
2024 Payments
$1,274
Companies
35
Transactions
247
Medicare Patients
5,572
Medicare Billing
$774,523
Payment Breakdown by Category
Food & Beverage$8,133 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,133 | 247 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $1,435 | 39 | $0 (2024) |
| Intersect ENT, Inc. | $1,256 | 14 | $0 (2022) |
| GENZYME CORPORATION | $980.38 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $867.17 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $842.84 | 40 | $0 (2024) |
| Spirox Inc | $371.09 | 1 | $0 (2017) |
| Stryker Corporation | $313.81 | 7 | $0 (2024) |
| Inspire Medical Systems, Inc. | $247.37 | 7 | $0 (2024) |
| Aerin Medical Inc. | $215.32 | 1 | $0 (2019) |
| Blueprint Medicines Corporation | $176.19 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,274 | 49 | GENZYME CORPORATION ($285.26) |
| 2023 | $1,597 | 59 | Regeneron Healthcare Solutions, Inc. ($393.89) |
| 2022 | $1,386 | 52 | Regeneron Healthcare Solutions, Inc. ($286.36) |
| 2021 | $656.13 | 22 | Optinose US, Inc. ($208.75) |
| 2020 | $345.88 | 11 | Optinose US, Inc. ($125.00) |
| 2019 | $1,107 | 15 | OptiNose US, Inc. ($417.77) |
| 2018 | $812.11 | 21 | Intersect ENT, Inc. ($390.35) |
| 2017 | $955.93 | 18 | Intersect ENT, Inc. ($412.21) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.95 | General |
| Category: Immunology | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $30.49 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.88 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/05/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $40.97 | General |
| Category: Oncology / Rare Diseases | ||||||
| 07/29/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROLOGY | ||||||
| 07/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: NEUROLOGY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Immunology | ||||||
| 07/03/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/25/2024 | Stryker Corporation | AUDION ET DILATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: ENTELLUS | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,662 | 2,285 | $770,564 | $230,800 |
| 2022 | 11 | 1,444 | 1,946 | $637,855 | $193,885 |
| 2021 | 11 | 1,359 | 1,989 | $592,007 | $203,098 |
| 2020 | 10 | 1,107 | 1,634 | $396,686 | $146,741 |
Total Patients
5,572
Total Services
7,854
Medicare Billing
$774,523
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 246 | 444 | $340,104 | $78,387 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 430 | 679 | $147,343 | $54,630 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 220 | $49,500 | $26,361 | 53.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 151 | 196 | $56,840 | $23,256 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $32,400 | $13,694 | 42.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 128 | 128 | $25,600 | $12,463 | 48.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 241 | 313 | $85,768 | $11,498 | 13.4% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 141 | 148 | $16,132 | $6,695 | 41.5% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 25 | 25 | $12,500 | $2,062 | 16.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 24 | $3,207 | $1,273 | 39.7% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 13 | 18 | $1,170 | $479.40 | 41.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 209 | 350 | $268,100 | $63,637 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 371 | 605 | $131,285 | $49,100 | 37.4% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 135 | 166 | $48,140 | $20,821 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 169 | 169 | $33,800 | $17,227 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 101 | $22,725 | $11,612 | 51.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 204 | 281 | $78,520 | $10,921 | 13.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $23,760 | $10,239 | 43.1% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 133 | 135 | $14,715 | $6,127 | 41.6% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 23 | 24 | $12,000 | $2,215 | 18.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 25 | $3,250 | $1,325 | 40.8% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 18 | 24 | $1,560 | $662.09 | 42.4% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 208 | 367 | $237,311 | $72,030 | 30.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 401 | 716 | $136,614 | $59,592 | 43.6% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 144 | 192 | $55,680 | $24,417 | 43.9% |
About Dr. B Schaeffer, MD
Dr. B Schaeffer, MD is a Facial Plastic Surgery healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336129550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. B Schaeffer, MD has received a total of $8,133 in payments from pharmaceutical and medical device companies, with $1,274 received in 2024. These payments were reported across 247 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,133).
As a Medicare-enrolled provider, Schaeffer has provided services to 5,572 Medicare beneficiaries, totaling 7,854 services with total Medicare billing of $774,523. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Facial Plastic Surgery
- Location New Hyde Park, NY
- Active Since 01/23/2006
- Last Updated 09/02/2021
- Taxonomy Code 207YS0123X
- Entity Type Individual
- NPI Number 1336129550
Products in Payments
- DUPIXENT (Biological) $1,848
- Xhance (Drug) $1,435
- PROPEL (Device) $970.51
- NUCALA (Biological) $750.52
- Latera (Device) $371.09
- SINUVA (Drug) $285.22
- INSPIRE (Device) $247.37
- Vivaer RF Stylus (Device) $215.32
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $183.19
- AYVAKIT (Drug) $176.19
- NEUROMARK Device (Device) $171.62
- Otovel (Drug) $158.57
- Xolair (Biological) $150.46
- CLARIFIX (Device) $120.10
- Ryaltris (Drug) $117.52
- TRELEGY ELLIPTA (Drug) $92.32
- AUDION ET DILATION SYSTEM (Device) $70.44
- Coblation - Laryngeal Wands (Device) $53.31
- Odactra (Drug) $48.36
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM (Device) $47.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.